Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monofer in IBD with iron deficiency anaemia
NCT01410435Phase 3Completed
- Sponsor
- Pharmacosmos
- Start
- Jun 2011
- Primary completion
- Aug 2013
- Countries
- 2
01
Overview
Phase 3, open-label, single-arm trial of ferric derisomaltose in iron deficiency anemia (FeDA), sponsored by Pharmacosmos. Primary endpoint: Ability to maintain a stable haemoglobin at 12 months. Started Jun 2011; status: completed.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (FeDA)
Beyond the preview
Go deeper on NCT01410435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01410435.